- AIM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3/A Filing
AIM ImmunoTech (AIM) S-3/AShelf registration (amended)
Filed: 20 Jul 18, 4:35pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on Form S-3 and related Prospectus of Hemispherx Biopharma, Inc. of our report dated March 30, 2018, relating to the consolidated financial statements of Hemispherx Biopharma, Inc. and subsidiaries, appearing in the Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2017.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus, which is a part of this Registration Statement.
/s/ RSM US LLP
Blue Bell, Pennsylvania
July 20, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.